Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Debt / NOTE 1.500%10/1
-
Number of holders
-
42
-
Total principal
-
271M
-
Principal change
-
-14.8M
-
Total reported value, excl. options
-
$383M
-
Value change
-
-$18.3M
-
Number of buys
-
13
-
Number of sells
-
-19
-
Price
-
$1.34
Significant Holders of BIOMARIN PHARMACEUTICAL INC - NOTE 1.500%10/1 as of Q4 2015
41 filings reported holding 09061GAF8 - BIOMARIN PHARMACEUTICAL INC - NOTE 1.500%10/1 as of Q4 2015.
BIOMARIN PHARMACEUTICAL INC - NOTE 1.500%10/1 has 42 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $271M of principal
.
Largest 10 bondholders include Invesco Ltd. ($36.2M of principal), Calamos Advisors LLC ($35.4M of principal), FRANKLIN RESOURCES INC ($29.7M of principal), ADVENT CAPITAL MANAGEMENT /DE/ ($24.1M of principal), ROYAL BANK OF CANADA ($20.3M of principal), Allianz Asset Management AG ($16.8M of principal), BlackRock Advisors LLC ($13.9M of principal), AMERIPRISE FINANCIAL INC ($9.81M of principal), FMR LLC ($9.73M of principal), and LORD, ABBETT & CO. LLC ($9.72M of principal).
This table shows the top 42 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.